Columns

My name is Dave and I’m Beth Shorthouse-Ullah’s husband. We had spoken about the possibility of writing a column that looks at the experiences of partners of people who have multiple sclerosis (MS). But instead of sharing a thought-provoking piece from another perspective, today I sadly announce that Beth…

I’m not a psychologist, but if you’re a regular reader of my column, you know that I’m intrigued by the subject. I seem to be particularly drawn to unusual conditions and making amateurish comparisons to multiple sclerosis (MS). In my defense, MS has odd symptoms, so…

About four years before I was diagnosed with multiple sclerosis (MS), someone else inadvertently “diagnosed” me. This person wasn’t medically trained, probably had no personal knowledge of MS, and didn’t actually use the words “multiple sclerosis.” Still, they gave me one of the best clues in my quest…

When my general practitioner first spoke about the possibility of a diagnosis of multiple sclerosis (MS) in February 2022, I walked out of his office. I broke down in tears; I was terrified. At that instant, my first thought was, “OK, so how long do I have left?”…

I’m not very good at this sort of thing, but depending on whether or not you count today and the 25th itself, we’ve got about four days left until Christmas. If I still needed to get my wife anything, I’d be entering shopping panic mode about now. Fortunately, I don’t…

When I was in the military, I wore several different hats. A U.S. Special Forces team has only 12 soldiers, so we couldn’t afford for anyone to know just one trick, no matter how good that trick might be. In addition to each person’s primary job, everyone had to know…

This is my 823rd column for Multiple Sclerosis News Today. It is also my last. Over the past seven and a half years, I’ve written about multiple sclerosis (MS) fatigue and frustration, about treatments and travel, about neurologists (good and bad), stress,…

Many years ago, I had an MRI scan on my right knee, and it didn’t go well. In fact, panic set in when I first looked at the scanner, as the tube seemed small. After I lay down and the operator started moving the table, I faced a…

I encountered multiple sclerosis (MS) for the first time in a Valdosta High School math class. Before my geometry teacher was diagnosed, I had never known anyone with the disease and, in all likelihood, was completely ignorant about it. I would hear the name again about 10 years…

Let me introduce myself: I’m Mike, and if you don’t mind, I’d like to share my story. I was diagnosed with multiple sclerosis (MS) in August 2022. Since then, a lot has changed, including the loss of a 20-year career, worsening mobility problems, and the start of…

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at some of what’s been happening: A good report for Vumerity Final results are in from the EVOLVE-MS-1 clinical trial for patients with…

For someone with multiple sclerosis (MS), going to a venue to see a concert or sporting event can be an experience filled with uncertainty — especially if, like me, they’re using a mobility aid. For me to do it, I have to ask myself several questions: How will I…

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at some of what’s been happening. MS relapses and COVID-19 Since COVID-19 became a concern over three years ago, I’ve read many comments…

It wasn’t a good morning. I was dragging my cement-pillar legs around the kitchen and grew frustrated as I lurched from the refrigerator to the counter to feed the cat and the dog. I’d propped my two canes against the counter, but they’d slid to the floor — not once,…

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: ATA188 fails a big test ATA188 is an experimental cell therapy developed by Atara Biotherapeutics aimed at easing MS…

As I’ve mentioned a time or two, my wife and I have three boys. Although they’re all under the age of 12, they’ve started to talk like the budding teenagers they are. As they mingle with peers more than their parents, their vocabulary in particular becomes less like ours every…

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Lemtrada or stem cell transplant? While the U.S. Food and Drug Administration has not yet approved stem cell transplants…

I slept through the night last night. Recently, I’ve managed to do that on most nights. No 4 a.m. bathroom trips for me! That’s a big deal. There was a time when I’d get up two or even three times during the night for a bladder run. Sleeping seven or…

There are a lot of things that I’m afraid of. That seems to come with the territory when you have a chronic disease like multiple sclerosis (MS), or when you’re a parent. At the same time, I don’t have any phobias that I’m aware of. To date, I…

Multiple Sclerosis News Today has been chronicling MS advocate and podcaster Mike Parker’s journey leading up to a skydiving jump he made on Oct. 29 to benefit the MS Society U.K. Learn more about Mike at mikesmsjourney.com. You can also donate to his fundraiser.  Last…

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Dalfampridine side effects The side effects that might occur if you use dalfampridine (sold under the brand name Ampyra)…

Halloween is five days away, and if you have kids, you’re running out of time to have your costumes ready. My wife and our three boys have everything figured out, minus some finishing touches — unless I want to dress up, of course. Fortunately, I wasn’t planning on it because…

Multiple Sclerosis News Today is chronicling MS advocate and podcaster Mike Parker’s journey, leading up to a skydiving jump he’ll make Oct. 29 to benefit the MS Society U.K. Learn more about Mike at mikesmsjourney.com. You can also donate to his fundraiser.  Third in a…

Welcome to “MS News Notes,” a column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. This week, the stories cover research presented at the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the…